Lilian Tina Minja
Biographic Data
| ID | 9064716 |
|---|---|
| NAME | Lilian Tina Minja |
| GIVEN NAMES | Lilian Tina |
| FAMILY NAME | Minja |
| SIGNATURE | MINJA L T |
| AFFILIATIONS | National Institute for Medical Research |
| ORCID | 0000-0002-9597-0207 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Refining research outcomes
Most tuberculosis diagnostic validation studies use microbiological or combination reference standards to define tuberculosis. We convened an Endpoint Review Committee (ERC) to define outcomes in ERASE-TB, a longitudinal cohort study across three high tuberculosis-burden countries, aimed at validating novel diagnostics for early detection. Herein, we describe processes and outcomes of the ERC. ERASE-TB enrolled 2,109 household contacts of people …
Prediction models for Mtb infection among adolescent and adult household contacts in high tuberculosis incidence settings
Tuberculosis household contacts are at high risk of developing tuberculosis. Tuberculosis preventive therapy (TPT) is highly effective, but implementation is hindered by limited accessibility of diagnostic tests aimed at detecting Mycobacterium tuberculosis ( Mtb) infection. Development of Mtb infection prediction models to guide clinical decision-making aims to overcome these challenges. We used data from 1905 tuberculosis household contacts (ag…
Optimizing delivery strategies for 3HP TB preventive treatment in Tanzania
Tanzania rolled-out a 12-dose, weekly regimen of isoniazid plus rifapentine (3HP) TB preventive treatment in January 2024. The 3HP completion rate is generally ≥80%, varying by delivery strategy and programmatic setting. Before the roll-out, a mixed methods study was conducted to assess whether a family approach involving family member support, SMS reminders, and three health education sessions was acceptable and optimized 3HP uptake and completi…
No prominent works on this page.
Optimizing delivery strategies for 3HP TB preventive treatment in Tanzania
Tanzania rolled-out a 12-dose, weekly regimen of isoniazid plus rifapentine (3HP) TB preventive treatment in January 2024. The 3HP completion rate is generally ≥80%, varying by delivery strategy and programmatic setting. Before the roll-out, a mixed methods study was conducted to assess whether a family approach involving family member support, SMS reminders, and three health education sessions was acceptable and optimized 3HP uptake and completi…
Prediction models for Mtb infection among adolescent and adult household contacts in high tuberculosis incidence settings
Tuberculosis household contacts are at high risk of developing tuberculosis. Tuberculosis preventive therapy (TPT) is highly effective, but implementation is hindered by limited accessibility of diagnostic tests aimed at detecting Mycobacterium tuberculosis ( Mtb) infection. Development of Mtb infection prediction models to guide clinical decision-making aims to overcome these challenges. We used data from 1905 tuberculosis household contacts (ag…
Refining research outcomes
Most tuberculosis diagnostic validation studies use microbiological or combination reference standards to define tuberculosis. We convened an Endpoint Review Committee (ERC) to define outcomes in ERASE-TB, a longitudinal cohort study across three high tuberculosis-burden countries, aimed at validating novel diagnostics for early detection. Herein, we describe processes and outcomes of the ERC. ERASE-TB enrolled 2,109 household contacts of people …
Tuberculosis Research and Epidemiology (3 works) · Medicine (2 works) · Tuberculosis (2 works) · Tuberculosis diagnosis (2 works) · Clinical endpoint (1 work) · Clinical Reasoning and Diagnostic Skills (1 work) · Cohort (1 work) · Cohort study (1 work) · Descriptive statistics (1 work) · Family medicine (1 work)